Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2022-09-19 2022-06-20
Drug Identification Number 02372436 02372436
Brand name STAXYN STAXYN
Common or Proper name VARDENAFIL VARDENAFIL
Company Name BAYER INC BAYER INC
Ingredients VARDENAFIL VARDENAFIL
Strength(s) 10MG 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 4's 4's
ATC code G04BE G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for discontinuation Other (Please describe in comments) Business reasons
Anticipated discontinuation date 2022-06-30
Actual discontinuation date
Remaining supply date 2018-11-13 2018-11-13
Discontinuation status Reversed To be discontinued
Discontinuation decision reversal yes no
Tier 3 Status No No
Information on remaining supply
Company comments Dormant DIN
Health Canada comments